Cancer Precision Medicine – Putting the Patient First

Learn More

Our Mission

NanoMab is a privately held biopharmaceutical company focusing on cancer precision therapies via the development of next generation radiopharmaceuticals.

LEARN MORE ABOUT US AND OUR TECHNOLOGY

We are developing medicine for fast and specific delivery of radiation to treat cancer. A therapeutic product is made by a camelid antibody labelled with a radioisotope of therapeutic radiation.

Learn More

COLLABORATORS

MANAGEMENT

Leadership Team

Nanomab is led by a highly experienced executive team with decades of experience across the pharmaceutical and life science sectors. 

LEARN MORE

Board of Directors

The Nanomab board is comprised of an expert range of senior executives and life science professionals with a deep variety of business  experience. 

LEARN MORE

Scientific Advisory Board

Nanomab is advised by an expert group of scientists with vast research experience across radiopharmaceuticals, oncology and pharmaceuticals.

LEARN MORE